Points from Letters: Pancreatitis from Oral Contraceptives

Murley, R. S.
January 1974
British Medical Journal;1/26/1974, Vol. 1 Issue 5899, p161
Academic Journal
No abstract available.


Related Articles

  • Wrong conclusions drawn, again. Brind, Joel // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/15/2010, Vol. 340 Issue 7755, p1050 

    A letter to the editor is presented in response to the article "Mortality Among Contraceptive Pill Users: Cohort Evidence From Royal College of General Practitioners' Oral Contraception Study," by Philip C. Hannaford and colleagues in the March 11, 2010 issue.

  • Update on Oral Contraceptive Pills. Cerel-Suhl, Sylvia L.; Yeager, Bryan F. // American Family Physician;11/1/1999, Vol. 60 Issue 7, p2073 

    Discusses oral contraceptive pills. Efficacy rates and patterns of oral contraceptive pill use; Benefits of oral contraceptive pills; Fears on the use of oral contraceptive pill; Precautions from the United Nations World Health organizations on taking oral contraceptive pill.

  • New extended-cycle OC.  // Cortlandt Forum;Jan2007, Vol. 20 Issue 1, p20 

    The article evaluates Seasonique, an oral contraceptive from Duramed Pharmaceuticals Inc.

  • LOSEASONIQUE.  // MPR - Obstetrician & Gynecologist Edition;2009, pA.5 

    The article evaluates the oral contraceptive Loseasonique from Duramed Pharmaceuticals Inc.

  • Oral contraceptive with 84-day regimen.  // Clinical Advisor;Jul2009, Vol. 12 Issue 7, p19 

    The article evaluates the LoSeasonique, an oral contraceptive from Duramed Inc.

  • OC with fewer periods.  // Cortlandt Forum;Sep2007, Vol. 20 Issue 9, p14 

    The article evaluates the oral contraceptive Lybrel from Wyeth Inc.

  • Yaz (3 mg drospirenone/20 µg ethinyl estradiol) Berlex, Inc.  // Clinician Reviews;Mar2007, Vol. 17 Issue 3, p52 

    The article evaluates the Yaz® oral contraceptive from Berlex Inc.

  • Oral contraceptives.  // Reactions Weekly;6/17/2006, Issue 1106, p16 

    Presents cases of benign paroxysmal positional vertigo resulting from the use of oral contraceptives. Types of oral contraceptives used by the patients; Symptoms experienced by the patients after using the oral contraceptives.

  • Study shows greater cancer risk. Hannaford, Philip C.; Iversen, Lisa; Lee, Amanda J.; Elliott, Alison M.; Selvaraj, Sivasubramaniam; Angus, Valerie // BMJ: British Medical Journal (International Edition);1/12/2008, Vol. 336 Issue 7635, p60 

    A response by Philip C. Hannaford to a letter written in response to his article "Cancer Risk Among Users of Oral Contraceptives: Cohort Data From the Royal College of General Practitioners' Oral Contraception Study" in the September 29, 2007 issue is presented.

  • Low-dose combination oral contraceptive.  // Modern Medicine;Sep98, Vol. 66 Issue 9, p64 

    Introduces a low-dosage combination of oral contraceptive from Berlex Laboratories Inc. Composition of the contraceptive.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics